KRT16P5

Across TCGA pan-cancer cohorts, KRT16P5 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of KRT16P5’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where KRT16P5 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types KRT16P5 is over-expressed in tumor, although a few such as BRCA and PRAD show the opposite, repressed pattern.

HNSC, BRCA, and LUSC are the cancer types where KRT16P5 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in KRT16P5 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	All	+1.097	<.001	9	view →
BRCA	Female	II,III,IV	−0.182	<.001	6	view →
LUSC	Male	All	+0.737	<.001	4	view →
PRAD	All	All	−0.150	.003	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

KRT16P5–HNSC

Open the HNSC breakdown →